Mirae Asset Global ETFs Holdings
MAZE

Mirae Asset Global ETFs Holdings’s Maze Therapeutics MAZE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$485K Buy
16,248
+3,832
+31% +$100K ﹤0.01% 2025
2026
Q1 		$371K Sell
12,416
-18,879
-60% -$833K ﹤0.01% 2042
2025
Q4 		$1.3M Buy
31,295
+22,217
+245% +$764K ﹤0.01% 1377
2025
Q3 		$235K Buy
9,078
+4,177
+85% +$70.5K ﹤0.01% 2247
2025
Q2 		$60.1K Sell
4,901
-234
-5% -$2.43K ﹤0.01% 2838
2025
Q1 		$56.5K Buy
+5,135
New +$61.8K ﹤0.01% 2825

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's MAZE Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Maze Therapeutics (MAZE) stake by 31% in Q2 2026, buying an estimated $100K and bringing the position to 16,248 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #2025.

Mirae Asset Global ETFs Holdings first reported a position in MAZE in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.3M in Q4 2025. 162 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 16,248 shares of Maze Therapeutics worth $485K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 3,832 Maze Therapeutics shares in Q2 2026, an estimated $100K.
  • Maze Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2025 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Maze Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Mirae Asset Global ETFs Holdings's Maze Therapeutics position peaked at $1.3M in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.